• Users Online: 845
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others

CURRICULUM IN CARDIOLOGY - STATISTICAL PAGES

Number needed to treat

Biswas Amitabh

Year : 2017| Volume: 3| Issue : 2 | Page no: 106-108

   This article has been cited by
 
1 Effect of tofacitinib on patient-reported outcomes in patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors in the phase III, randomised controlled trial: OPAL Beyond
Vibeke Strand,Kurt de Vlam,Jose A Covarrubias-Cobos,Philip J Mease,Dafna D Gladman,Linda Chen,Elizabeth Kudlacz,Joseph Wu,Joseph C Cappelleri,Thijs Hendrikx,Ming-Ann Hsu
RMD Open. 2019; 5(1): e000808
[Pubmed]  [Google Scholar] [DOI]
2 Results of studying the clinical efficacy and safety of tofacitinib in the treatment of psoriatic arthritis
T. V. Korotaeva,E. Yu. Loginova
Modern Rheumatology Journal. 2019; 13(2): 112
[Pubmed]  [Google Scholar] [DOI]
3 Tofacitinib or adalimumab versus placebo: patient-reported outcomes from OPAL Broaden—a phase III study of active psoriatic arthritis in patients with an inadequate response to conventional synthetic disease-modifying antirheumatic drugs
Vibeke Strand,Kurt de Vlam,Jose A Covarrubias-Cobos,Philip J Mease,Dafna D Gladman,Daniela Graham,Cunshan Wang,Joseph C Cappelleri,Thijs Hendrikx,Ming-Ann Hsu
RMD Open. 2019; 5(1): e000806
[Pubmed]  [Google Scholar] [DOI]
4 Novel Mineral–Vitamin Treatment for Reduction in Cigarette Smoking: A Fully Blinded Randomized Placebo-Controlled Trial
Phillipa K Reihana,Neville M Blampied,Julia J Rucklidge
Nicotine & Tobacco Research. 2018;
[Pubmed]  [Google Scholar] [DOI]

 

Read this article